Latest News

A group of researchers from Goethe University and University Hospital Frankfurt demonstrates that an inhibitor against microRNA-92a is effective in humans. The German Centre for Cardiovascular Research (DZHK) supported this clinical trial.

A surprising finding by scientists from the University Medical Center Hamburg-Eppendorf (UKE) reveals that the coronavirus can attack the heart and alter the gene activity of infected heart cells. That is the result of a recent study by DZHK scientist Prof. Dr. Dirk Westermann...

East Germany has many more hospitalisations for heart failure compared to West Germany despite a nationwide healthcare system, according to research presented by DZHK scientist Professor Marcus Dörr of University Medicine Greifswald on HFA Discoveries, a scientific platform of...

6.5 million US dollars for transatlantic expert network "Editing the Failure Heart": Scientists from Great Britain, the Netherlands, the United States of America, and the DZHK partner site in Göttingen are researching new approaches to repairing heart disease using genetic...

British, Dutch, and German scientists are collaborating on joint projects to investigate essential issues in cardiovascular medicine. The organisations British Heart Foundation (BHF), Hartstichting, and the German Centre for Cardiovascular Research (DZHK) have set up a joint...

When patients are admitted to the hospital with chest pain, it is crucial to determine as quickly as possible whether or not a heart attack has occurred. By combining artificial intelligence and RNA molecules, scientists at the German Centre for Cardiovascular Research (DZHK)...

After a stroke or heart attack, patients often receive aspirin to counteract renewed vascular occlusion. Whether the blood thinner is also useful in primary prevention in people who have not yet suffered a cardiovascular event is controversial. DZHK scientist PD Dr. med. Thorsten...

Researchers of the Ludwig-Maximilians-Universität München (LMU) have discovered a hitherto unknown molecular function of a specific microRNA that preserves integrity of the endothelium and reduces the risk of atherosclerosis.

The German Research Foundation (DFG) is funding the Collaborative Research Centre SFB 1002 "Modulatory Units in Heart Failure" at the University Medical Centre Göttingen (UMG) for another four years. In the third funding period starting in July 2020, the SFB will receive...